Left ventricular hypertrophy and endothelial dysfunction in chronic kidney disease

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 1, 2014, Pages 56-61

  Poulikakos, Dimitrios ^a,b   Ross, Louise ^a,b   Recio Mayoral, Alejandro ^b   Cole, Della ^b   Andoh, Jocelyn ^b   Chitalia, Nihil ^a,b   Sharma, Rajan ^b   Carlos Kaski, Juan ^b   Banerjee, Debasish ^a,b  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

chronic kidney disease; endothelial function; left ventricular hypertrophy

Indexed keywords

C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PILOT STUDY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SMOKING; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND SCANNER;

CHRONIC KIDNEY DISEASE; ENDOTHELIAL FUNCTION; LEFT VENTRICULAR HYPERTROPHY;

BRACHIAL ARTERY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84891465129     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jet120     Document Type: Article

References (46)

1. Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003; 42:677-84.
2. GoAS,ChertowGM, Fan D, McCulloch CE, HsuCY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-305.
3. Ojo AO, Hanson JA,Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000;57:307-13.
4. Guerin AP, Marchais SJ, Metivier F, London GM. Arterial structural and functional alterations in uraemia. Eur J Clin Invest 2005;35(Suppl. 3):85-8.
5. Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London GM. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 2000;57:1091-9.
6. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-41.
7. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97.
8. Recio-Mayoral A, BanerjeeD, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease- A cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011; 216:446-51.
9. Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis 2012;220:265-8.
10. Satoh M. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol 2012;16:518-21.
11. Lazdam M, Lewandowski AJ, Kylintireas I, Cunnington C, Diesch J, Francis J et al. Impaired endothelial responses in apparently healthy young people associated with subclinical variation in blood pressure and cardiovascular phenotype. Am J Hypertens 2012;25:46-53.
12. Yeboah J, Crouse JR, Bluemke DA, Lima JA, Polak JF, Burke GL et al. Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA). J Hum Hypertens 2011;25:25-31.
13. Arici M,Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001;59:407-14.
14. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35:469-76.
15. Menon V, Greene T,Wang X, Pereira AA, Marcovina SM, Beck GJ et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int 2005;68:766-72.
16. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002;99-102.
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
18. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.
19. Newey VR, Nassiri DK. Online artery diameter measurement in ultrasound images using artificial neural networks. Ultrasound Med Biol 2002;28:209-16.
20. Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S et al. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant 2011;26:3537-43.
21. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78:539-52.
22. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26.
23. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endotheliumdependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
24. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106:653-8.
25. Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010;5:805-13.
26. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-92.
27. Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, GuttmannRD. Left ventricular hypertrophy in end-stage renal disease. Nephron 1988;48:107-15.
28. Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T et al. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography. J Nephrol 2012;25:794-801.
29. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003;16:111-7.
30. Martinez-Vea A, Marcas L, Bardaji A, Romeu M, Gutierrez C, Garcia C et al. Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. Clin Nephrol 2012;77:171-81.
31. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 2001;104:1286-91.
32. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007;117:568-75.
33. Toikka JO, Niemi P, Ahotupa M, Niinikoski H, Viikari JS, Ronnemaa T et al. Large-artery elastic properties in young men: relationships to serum lipoproteins and oxidized low-density lipoproteins. Arterioscler Thromb Vasc Biol 1999;19:436-41.
34. Wilkinson IB, Prasad K, Hall IR, Thomas A, MacCallum H,Webb DJ et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002;39:1005-11.
35. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-9.
36. McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin, Newby DE et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006;48:602-8.
37. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996;50:600-8.
38. Temmar M, Liabeuf S, Renard C, Czernichow S, Esper NE, Shahapuni I et al. Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 2010;28:163-9.
39. Verbeke FH, Agharazii M, Boutouyrie P, Pannier B, Guerin AP, London GM. Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol 2007;18:621-8.
40. Hashimoto J,Westerhof BE,Westerhof N, Imai Y, O'Rourke MF. Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. J Hypertens 2008;26:1017-24.
41. Kobayashi S, Yano M, Kohno M, Obayashi M, Hisamatsu Y, Ryoke T et al. Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation 1996;94:3362-8.
42. Chirinos JA, Kips JG, JacobsDR Jr, Brumback L, DuprezDA, Kronmal R et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol 2012;60:2170-7.
43. Yildiz A, Oflaz H, Pusuroglu H, Mercanoglu F, Genchallac H, Akkaya V et al. Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients. Am J Kidney Dis 2003;41:616-23.
44. Wilcox CS. Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension 2012; 59:375-81.
45. Salles GF, Fiszman R, Cardoso CR, Muxfeldt ES. Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension. Hypertension 2007;50:723-8.
46. van Bussel BC, Schouten F, Henry RM, Schalkwijk CG, de Boer MR, Ferreira I et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension 2011;58:588-95.